Industry reports
Editor highlights

Search inside this page

All regions

Free Market Research Guides to Download

Biopharmaceutical Industry: Market Research Reports, Statistics and Analysis

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
5 reviews

(Photo: Stock.xchng)

Global Biopharmaceutical Industry

 

The global biopharmaceutical industry is currently worth over $145 billion, according to research conducted by BioPlan Associates. The industry should exceed $167 billion in 2015, says IMARC. 

 

Biopharmaceuticals are used in the prevention and treatment of disease, and there are over 300 approved biopharmaceuticals on the market, with many in clinical development yet to come. The market has benefited from the need for pharmaceutical manufacturers to boost output, but it has a high risk factor, with only three out of 10 drugs that pass to the clinical phase receiving market clearance.

 

Cost containment and biosimilar entry in developed markets continue to see slow growth, but the market should expand thanks to biopharmaceutical capacity to outperform traditional small molecule drugs. Over the coming five-year period, factors such as development of emerging markets and a rich late-stage pipeline are expected to fuel growth.

 

 

...
More »

You might be interested in: biosimilar, protein, bioprocessing, more »

» View Public Reports

1-10 of about 600 reports

World Biopharmaceutical Industry Overview

  • Industry report
  • October 2012
  • 27 pages

... monoclonal antibodies new products based on new science, these pose challenges in terms of industrialization and cost effectiveness tissue engineering cell therapies - autologous & allogeneic gene ...

  • Industries: Biopharmaceutical
  • Countries: World

Biopharmaceutical Sector in The United States and Canada

  • Industry report
  • May 2013
  • 22 pages

... Electrophoresis (sds- page) (10%) and transferred to pvdf membrane. To detect the recombinant protein the membrane was incubated with primary mouse anti-c-myc monoclonal antibody (genscript, a00864, piscataway ...

  • Industries: Biopharmaceutical
  • Countries: United States, Canada

The European Biopharmaceutical Industry

  • Industry report
  • March 2012
  • 8 pages

... Processes. Hence, they cannot be subject to the price regulation mechanisms for generics. The european medicines agency (ema) has explicitly stated that biosimilars are not generics by definition ...

  • Industries: Biopharmaceutical
  • Countries: Germany, Europe

The Asian Biopharmaceutical Industry Brief

  • Industry report
  • July 2013
  • 31 pages

... Select sure lx, capto impres, capto l, capto core 700, paa cell culture media, xcellerex , primer support 5g pure insulin pure plasma proteins recombinant insulin monoclonal antibodies cell ...

  • Industries: Biopharmaceutical
  • Countries: Asia

The German Biopharmaceutical Business

  • Industry report
  • February 2013
  • 32 pages

... But this system lacks mechanisms to carry out posttranslational modifications. Today, plants represent an alternative for production of recombinant proteins. As bioreactors, they offer the possibility ...

  • Industries: Biopharmaceutical
  • Countries: Germany

The British Biopharmaceutical Business : Innovation and Technology Trends

  • Industry report
  • December 2012
  • 33 pages

... Eurostars tsb national- sbri, ktp, biomedical catalyst devolved administration/regional funding- manufacturing advisor service (mas) t e c h n o lo g y r e a d in e s s l e v e l (t r l ) t e c h n o lo g ...

  • Industries: Biopharmaceutical
  • Countries: United Kingdom

Biopharmaceutical in The United States and Canada : Innovation and Technology Trends

  • Industry report
  • August 2012
  • 26 pages

... Information, future events or otherwise. Nothing herein should be construed as an offering of securities of the company in any jurisdictions. 3 Company overview focus vaccines / biosimilars ...

  • Industries: Biopharmaceutical
  • Countries: United States, Canada

Biopharmaceutical Key Market Figures in India

  • Industry report
  • July 2013
  • 15 pages

... Companies and professional service providers, in both r&d and manufacturing of therapeutic proteins, mabs and peptides. Moreover, the report also discussed in detail the current biopharma outsourcing ...

  • Industries: Biopharmaceutical
  • Countries: India

Biopharmaceutical Key Market Figures in China

  • Industry report
  • July 2013
  • 16 pages

... Of funding opportunities to chinese companies conducting innovative biologic drug r&d ---------------------------------- 81 2.4.4 Fast enriching innovative biologic drug pipeline of chinese ...

  • Industries: Biopharmaceutical
  • Countries: China

Biopharmaceutical Sector in South Korea

  • Industry report
  • May 2012
  • 13 pages

... And production of monoclonal antibodies and antibody-based protein drugs. We carry out environmental management activities that meet the company S mid- to long-term strategies and the policies of its ...

  • Industries: Biopharmaceutical
  • Countries: South Korea
Search in Biopharmaceutical Industry (About 600 reports)

» Purchase Premium Reports (From $ 55 - $ 5 369)

About 1 000 reports
Biosimilar Index: Tracking the Global Biosimilar Pipeline

Biosimilar Index: Tracking the Global Biosimilar Pipeline

  • $ 5 369
  • Industry report
  • April 2014
  • by Firstword Pharma

Biosimilar Index answers your questions, such as... - There are 15 biosimilar and non-comparable biologic (NCB) versions of bevacizumab (Avastin; Roche) in clinical development; with the Biosimilar Index ...

Commercial Potential Of The Forthcoming Us Biosimilars ...

February 2014 $ 5 000

Opportunity In The Indian Protein A Media Market - 2014

January 2014 $ 5 000

Membrane Technology Market In Pharmaceutical, Biopharma ...

March 2014 $ 4 795

Alcohol And Starch/sugar Enzyme Market By Type (carbohy ...

March 2014 $ 4 650

Baking Enzymes Market By Geography (north America, Euro ...

March 2014 $ 4 650

Industrial Enzymes Market By Types (carbohydrase, Prote ...

March 2014 $ 4 650

Specialty Enzymes Market By Source (microorganism, Plan ...

March 2014 $ 4 650

Global Biosimilars Market 2014-2018

February 2014 $ 3 000

Antibody-drug Conjugates 2014 - A Business, Technology ...

January 2014 $ 2 838

» Read our Company Profiles

3 Companies

Repligen Corp.

United States

Biocon Ltd.

India

MorphoSys AG

Germany

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.